Patents by Inventor Anthony de Belder

Anthony de Belder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rhodamine dyes and conjugates
    Patent number: 11618825
    Abstract: The present invention relates generally to novel rhodamine dyes which upon conjugation with another molecule form single isomeric conjugation products. These novel rhodamine dyes contain only one single functional group on the rhodomine molecule for conjugation so that their conjugation products are single isomeric conjugation products.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: April 4, 2023
    Assignee: PHARMACOPHOTONICS, INC.
    Inventors: Ulf J. Bremberg, Erik Ringberg, Wei Berts, Anthony De Belder, James S. Strickland
  • RHODAMINE DYES AND CONJUGATES
    Publication number: 20210403719
    Abstract: The present invention relates generally to novel rhodamine dyes which upon conjugation with another molecule form single isomeric conjugation products. These novel rhodamine dyes contain only one single functional group on the rhodomine molecule for conjugation so that their conjugation products are single isomeric conjugation products.
    Type: Application
    Filed: September 8, 2021
    Publication date: December 30, 2021
    Inventors: Ulf J. Bremberg, Erik Ringberg, Wei Berts, Anthony De Belder, James S. Strickland
  • Rhodamine dyes and conjugates
    Patent number: 11130865
    Abstract: The present invention relates generally to novel rhodamine dyes which upon conjugation with another molecule form single isomeric conjugation products. These novel rhodamine dyes contain only one single functional group on the rhodomine molecule for conjugation so that their conjugation products are single isomeric conjugation products.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: September 28, 2021
    Assignee: PHARMACOPHOTONICS, INC.
    Inventors: Ulf J. Bremberg, Erik Ringberg, Wei Berts, Anthony De Belder, James S. Strickland
  • NOVEL RHODAMINE DYES AND CONJUGATES
    Publication number: 20200109289
    Abstract: The present invention relates generally to novel rhodamine dyes which upon conjugation with another molecule form single isomeric conjugation products. These novel rhodamine dyes contain only one single functional group on the rhodomine molecule for conjugation so that their conjugation products are single isomeric conjugation products.
    Type: Application
    Filed: December 6, 2019
    Publication date: April 9, 2020
    Applicant: PharmacoPhotonics, Inc. d/b/a FAST BioMedical
    Inventors: Ulf J. Bremberg, Erik Ringberg, Wei Berts, Anthony De Belder, James S. Strickland
  • Rhodamine dyes and conjugates
    Patent number: 10501630
    Abstract: The present invention relates generally to novel rhodamine dyes which upon conjugation with another molecule form single isomeric conjugation products. These novel rhodamine dyes contain only one single functional group on the rhodomine molecule for conjugation so that their conjugation products are single isomeric conjugation products.
    Type: Grant
    Filed: April 9, 2018
    Date of Patent: December 10, 2019
    Assignee: PHARMACOPHOTONICS, INC.
    Inventors: Ulf J. Bremberg, Erik Ringberg, Wei Berts, Anthony De Belder, James S. Strickland
  • NOVEL RHODAMINE DYES AND CONJUGATES
    Publication number: 20190016896
    Abstract: The present invention relates generally to novel rhodamine dyes which upon conjugation with another molecule form single isomeric conjugation products. These novel rhodamine dyes contain only one single functional group on the rhodomine molecule for conjugation so that their conjugation products are single isomeric conjugation products.
    Type: Application
    Filed: April 9, 2018
    Publication date: January 17, 2019
    Inventors: Ulf J. Bremberg, Erik Rinbgerg, Wei Berts, Anthony De Belder, James S. Strickland
  • Rhodamine dyes and conjugates
    Patent number: 9938410
    Abstract: The present invention relates generally to novel rhodamine dyes which upon conjugation with another molecule form single isomeric conjugation products. These novel rhodamine dyes contain only one single functional group on the rhodomine molecule for conjugation so that their conjugation products are single isomeric conjugation products.
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: April 10, 2018
    Assignee: PHARMACOPHOTONICS, INC.
    Inventors: Ulf J. Bremberg, Erik Rinbgerg, Wei Berts, Anthony De Belder, James S. Strickland
  • NOVEL RHODAMINE DYES AND CONJUGATES
    Publication number: 20160208101
    Abstract: The present invention relates generally to novel rhodamine dyes which upon conjugation with another molecule form single isomeric conjugation products. These novel rhodamine dyes contain only one single functional group on the rhodomine molecule for conjugation so that their conjugation products are single isomeric conjugation products.
    Type: Application
    Filed: October 26, 2015
    Publication date: July 21, 2016
    Inventors: Ulf J. Bremberg, Erik Rinbgerg, Wei Berts, Anthony De Belder, James S. Strickland
  • Rhodamine dyes and conjugates
    Patent number: 9169398
    Abstract: The present invention relates generally to novel rhodamine dyes which upon conjugation with another molecule form single isomeric conjugation products. These novel rhodamine dyes contain only one single functional group on the rhodomine molecule for conjugation so that their conjugation products are single isomeric conjugation products.
    Type: Grant
    Filed: May 21, 2014
    Date of Patent: October 27, 2015
    Assignee: Pharmacophotonics, Inc.
    Inventors: Ulf Bremberg, Erik Ringberg, Wei Berts, Anthony De Belder, James S. Strickland
  • NOVEL RHODAMINE DYES AND CONJUGATES
    Publication number: 20140256946
    Abstract: The present invention relates generally to novel rhodamine dyes which upon conjugation with another molecule form single isomeric conjugation products. These novel rhodamine dyes contain only one single functional group on the rhodomine molecule for conjugation so that their conjugation products are single isomeric conjugation products.
    Type: Application
    Filed: May 21, 2014
    Publication date: September 11, 2014
    Applicant: PHARMACOPHOTONICS, INC. D/B/A FAST DIAGNOSTICS
    Inventors: Ulf BREMBERG, Erik RINGBERG, Wei BERTS, Anthony De BELDER, James S. STRICKLAND
  • Rhodamine dyes and conjugates
    Patent number: 8809531
    Abstract: The present invention relates generally to novel rhodamine dyes which upon conjugation with another molecule form single isomeric conjugation products. These novel rhodamine dyes contain only one single functional group on the rhodomine molecule for conjugation so that their conjugation products are single isomeric conjugation products.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: August 19, 2014
    Assignee: PharmacoPhotonics, Inc.
    Inventors: Ulf Bremberg, Erik Ringberg, Wei Berts, Anthony De Belder, James S. Strickland
  • NOVEL RHODAMINE DYES AND CONJUGATES
    Publication number: 20130096309
    Abstract: The present invention relates generally to novel rhodamine dyes which upon conjugation with another molecule form single isomeric conjugation products. These novel rhodamine dyes contain only one single functional group on the rhodomine molecule for conjugation so that their conjugation products are single isomeric conjugation products.
    Type: Application
    Filed: April 1, 2011
    Publication date: April 18, 2013
    Inventors: Ulf Bremberg, Erik Ringberg, Wei Berts, Anthony De Belder, James S. Strickland
  • Therapeutical composition comprising hydrolyzed carboxylalkyl cellulose
    Patent number: 5324717
    Abstract: A therapeutical composition comprising hydrolyzed carboxyalkyl cellulose, wherein alkyl is methyl, ethyl or propyl, optionally in salt form, which hydrolyzed carboxyalkyl cellulose has a mass average molecular mass from about 200 to about 10,000. A method for providing a laxative effect comprises the administration of such a composition.
    Type: Grant
    Filed: November 4, 1992
    Date of Patent: June 28, 1994
    Inventors: Thomas Berglindh, Anthony de Belder